FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • FAQ
  • How to use FRC

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
CompuMed, Inc. Stock AnalysisComprehensive stock analysis for CompuMed, Inc. (CMPD) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisCMPD
CMPD
CompuMed, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
CMPD
Home🔹Stocks🔹CompuMed, Inc.

CompuMed, Inc.

🇺🇸CMPD•OTC

CompuMed, Inc.

🇺🇸CMPD•OTC
Market cap
$6.34M
Sentiment

Your view on CMPD

Mkt Cap
$6.34M
Sentiment
Your view
CMPD
CompuMed, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
CMPD
Company Overview

Overview

What the company does, where it operates, and who runs it.

About CompuMed, Inc.

Industry
Medical - Healthcare Information Services
Sector
Healthcare
CEO
Lee Keddie
Headquarters
5777 West Century Boulevard, Los Angeles, CA, US
Industry
Medical - Healthcare Information Services
Sector
Healthcare
CEO
Lee Keddie
Headquarters
5777 West Century Boulevard, Los Angeles, CA, US
Description

CompuMed, Inc., an enterprise telemedicine solutions company, provides clinical care services for patients and medical facilities. It offers telecardiology and teleradiology services that provide real-time access to U.S. Board-Certified specialists through cloud-based technology and integrated medical devices to medical facilities worldwide.

The company also provides enterprise telemedicine solutions; a suite of telecardiology services and diagnostic exam interpretations for pediatric and adult patients, including electrocardiogram (ECG) devices, echocardiogram, ECG, vascular, holter, nuclear, and video consults; and reading, transcription, reporting, storage, and video consultations in the areas of Vscan, X-ray, ultrasound, mammography, computed tomography, magnetic resonance imaging, and radiologist video consults.

It also offers OsteoGram software that works in combination with standard or digital X-ray equipment to support osteoporosis screening, diagnosis, and therapy monitoring. In addition, the company provides mobile ECG and ultrasound solutions that provide patients with immediate access to its board-certified specialists; and medical devices.

It serves organ procurement organizations, rural healthcare, and correctional healthcare industries. CompuMed, Inc. was founded in 1973 and is headquartered in Los Angeles, California.

FRC Research

Media

Infographics, videos, and posts covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks it is worth vs. the current price.

FRC's fair value estimate for CompuMed, Inc., and the rating behind it. CMPD last traded at $4.80; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for CompuMed, Inc.. Starting points for CompuMed, Inc.: EPS -$0.22, beta -0.28 — an Medical - Healthcare Information Services name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for CompuMed, Inc.. CompuMed, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for CompuMed, Inc.. Trailing twelve-month EPS for CompuMed, Inc. stands at -$0.22. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for CompuMed, Inc.. CompuMed, Inc. has reported as a listed company since 1987. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

CompuMed, Inc. valued side by side against its closest peers. CompuMed, Inc. is measured against Medical - Healthcare Information Services peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Premium

Which funds and firms own the stock.

Which institutions hold CompuMed, Inc., and how their positions are changing. At a $6.3M market value, institutional positions materially move CompuMed, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Insider Trading

Premium

Recent buying and selling by company executives.

Buying and selling by CompuMed, Inc. executives and directors. Shares of CompuMed, Inc. have traded between $1.95 and $6.80 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

Senate Trading

Premium

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming CompuMed, Inc.. CompuMed, Inc. is a $6.3M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

House Trading

Premium

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming CompuMed, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

News

Latest headlines and market coverage.

Latest headlines and company announcements for CompuMed, Inc.. Coverage tracks CompuMed, Inc. within Medical - Healthcare Information Services (Healthcare). Press releases and market coverage, newest first.

Peer companies

  • CLABF — Core One Labs Inc.
  • CNGGF — Cann Group Limited
  • CPMV — Mosaic ImmunoEngineering Inc.
  • DOGP — Dogecoin Cash, Inc.
  • FNAM — Evolutionary Genomics, Inc.
  • HLYK — HealthLynked Corp.
  • RSCF — Reflect Scientific, Inc.
  • TDSGF — Telo Genomics Corp.

More Medical - Healthcare Information Services companies

  • WMGR — Wellness Matrix Group, Inc.
  • XSVT — Xsovt Brands, Inc.
  • ZCMD — Zhongchao Inc.
  • PASO — Patient Access Solutions, Inc.
  • PCK.AX — PainChek Limited
  • PHR — Phreesia, Inc.
  • PIAHY — Ping An Healthcare and Technology Company Limited
  • PINC — Premier, Inc.
  • PKY.AX — Pathkey.AI Ltd
  • PMCUF — Pro Medicus Limited
  • PME.AX — Pro Medicus Limited
  • PPJE — PPJ Healthcare Enterprises, Inc.

News

Latest Market News